Compare RGS & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGS | AIDX |
|---|---|---|
| Founded | 1922 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.3M | 58.8M |
| IPO Year | 1994 | N/A |
| Metric | RGS | AIDX |
|---|---|---|
| Price | $21.31 | $2.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.7K | ★ 318.0K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.24 | N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $210,134,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $32.81 | ★ N/A |
| Revenue Growth | ★ 3.52 | N/A |
| 52 Week Low | $15.00 | $2.42 |
| 52 Week High | $31.50 | $14.09 |
| Indicator | RGS | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 40.27 | 4.83 |
| Support Level | $18.63 | N/A |
| Resistance Level | $23.67 | $3.08 |
| Average True Range (ATR) | 0.86 | 1.23 |
| MACD | -0.06 | -0.25 |
| Stochastic Oscillator | 44.27 | 0.51 |
Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.